Dona B. Reber, MEd, SM (NCRM) AccurateMicrobiology.com

Dona Reber's 30+ years of experience started in clinical microbiology, moved to academic research and for the majority has focused on biopharmaceutical  microbiology, contamination control strategies for aseptic/nonaseptic manufacturing, microbiology testing and development, managing and networking microbiologists for laboratory and manufacturing issues. Current activities include assessments, training for low bioburden and sterile injectables facilities, investigations, troubleshooting, and developing global policy documents. She is a longtime chair of the Pharmaceutical Micro Expert Discussion Group. Dona has trained new FDA inspectors on environmental monitoring and is a PDA instructor for TR#13, Fundamentals of an Environmental Control Program. She is a contributing author to PDA Technical Report #70, Disinfection; TR# 67, Objectionable Organism; and TR#13. She is  participating in revisions to TR#13, including for Low Bioburden Processes, and a new TR for Contamination Control. She is co-author of A Risk Assessment Approach to Microbiological Controls of Cellular Therapies (Journal of Science and Technology, expected in 2019); co-editor of two PDA Books, Microbial Identifications:  The Keys to a Successful Program (2012) and Microbial Control and Identification:  Strategies, Methods Applications  (2018). She was awarded PDA Editor of the Year in 2018 for her latest book.
Dona enjoys bicycling and supporting science career programs.